相关产品推荐更多 >

重组抗CD146/MCAM单抗 | Recombinant Anti-CD146/MCAM Monoclonal Antibody, NBAB-109113
询价
重组抗Latexin单抗 | NebuSelect™ Recombinant Anti-Latexin Monoclonal Antibody
询价
抗Interferon alpha 1/IFNA1单抗 | Anti-Interferon alpha 1/IFNA1 Monoclonal Antibody
询价
GSTP1/GST3多抗 | Anti-GSTP1/GST3 Polyclonal Antibody
询价
抗SLEV NS3/Serine protease NS3多抗 | Anti-SLEV NS3/Serine protease NS3 Polyclonal Antibody
询价
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AI 赋能培养基定制开发:CHO 培养基是如何实现产量提升Cytoscape 教程来了!快速实现顶刊同款通路网络图五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant Human HPGD / 15-PGDH protein
- 形态:
liquid
- 保存条件:
见COA
- 克隆性:
单克隆
- 保质期:
见COA
- 库存:
大量
- 供应商:
北京辰辉创聚生物技术有限公司
- 应用范围:
FCM; ICC/IF
- 抗体英文名:
Recombinant Anti-15-PGDH Monoclonal Antibody
- 抗体名:
重组抗15-PGDH单抗
- 规格:
100ul; 500ul; 1ml

| 产品信息
品名:NebuSelect™ Recombinant Anti-15-PGDH Monoclonal Antibody
货号:NBAB-106771
品牌:辰辉创聚生物®️
规格:100ul; 500ul; 1ml
| 产品描述
NebuSelect™ Recombinant Anti-15-PGDH Monoclonal Antibody (CAT# NBAB-106771) was produced from a rabbit immunized with purified, recombinant Human HPGD / 15-PGDH.
| 产品属性
Product Category:Rabbit MAb
Reactivity:Human
Specificity:Human 15-PGDH
Immunogen:Recombinant Human HPGD / 15-PGDH protein
Isotype:Monoclonal Rabbit IgG
Purification:Protein A
Buffer:0.2 μm filtered solution in PBS
Conjugate:Unconjugated
Applications:FCM; ICC/IF
Dilution:ICC-IF: 1:20-1:100 FCM:1:25-1:100
Storage:This liquid antibody can be stored at 2℃-8℃ for at least two weeks. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or antibody diluent, the antibody is stable for at least two weeks at 2-4℃.
For Research Use Only!
To get more information, please contact us freely.
郑重声明:仅用于科学研究,不可用于诊断或治疗。
更多产品细节,请联系我司相关客服人员。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Production of Monoclonal Antibody by DNA Immunization with Electroporation
DNA immunization with in vivo electroporation is an efficient alternative protocol for the production of monoclonal antibodies (mAb). Generation of mAb by DNA immunization is a novel approach to circumvent the following technical hurdles
Antibody (Biotin Conjugate) (GMP-Grade) #22985 验证数据:Whitlow/218 Linker (E3U7Q) Rabbit Monoclonal Antibody (PE Conjugate) #62405 CST全新推出GMP级G4S Linker重组单抗,将抗linker抗体的应用场景从临床前科研延伸到CAR-T体外生产、过程质控与批次放行。 ・ 包含两种偶联形式:生物素标记版本适配磁珠平台,用于CAR阳性细胞富集,缓解低转导效率带来的工艺挑战;PE
因子,以可溶性形式存在于体液中,能招募并激活巨噬细胞、中性粒细胞等免疫细胞,增强其迁移和吞噬能力,从而协同清除病原体。 补体药物 鉴于补体系统在多种疾病中的致病作用,其效应分子已成为重要的治疗靶点。近年来,多款补体抑制剂相继上市。2007年,抗C5单抗eculizumab(Soliris)获批用于阵发性睡眠性血红蛋白尿症(PNH),开启补体靶向治疗时代。随后,C1抑制剂Cinryze用于遗传性血管水肿。2018年,长效C5抑制剂ravulizumab(Ultomiris)获批,延长给药间隔至每8周一
技术资料暂无技术资料 索取技术资料





